Conditions We Treat
- Adrenal Cancer
- Anal Cancer
- Bladder Cancer
- Bone Cancer
- Brain Tumors
- Breast Cancer
- Carcinoid Tumor
- Chest Wall Tumor
- Cervical Cancer
- Colon Cancer
- Cutaneous Lymphoma
- Diaphragm Tumor
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Head And Neck Cancer
- Hodgkin's Lymphoma
- Kaposi’s Sarcoma
- Kidney Cancer
- Laryngeal (Voice Box) Cancer
- Liver Cancer
- Lung Cancer
- Mediastinal Tumor
- Multiple Myeloma
- Nasopharyngeal Cancer
- Non-Hodgkin Lymphoma
- Oral Cancer
- Oropharyngeal Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Rectal Cancer
- Sickle Cell Disease
- Skin Cancer
- Stomach Cancer
- Testicular Cancer
- Throat Cancer
- Thyroid Cancer
- Tongue Cancer
- Uterine Cancer
- Breast Cancer Program
- CAR T-cell Therapy Program
- Cutaneous Cancer Program
- Gastrointestinal Cancer Program
- Genitourinary Cancer Program
- Gynecologic Cancer Program
- Head and Neck Cancer Program
- Hematologic Cancer Program
- Neuroendocrine Tumor Program
- Oral Maxillofacial Surgery Oncology Program
- Sarcoma Program
- Sickle Cell Disease Program
- Stem Cell Transplant and Cellular Therapy Program
- Thoracic Cancer Program
Clinical Support Services
Resources for Patients
Cancer Center Support
BMC researchers are finding innovative new ways to treat and cure cancers, including cancers of the breast, lung, colon, prostate, head and neck, blood cells (leukemia and lymphoma), and more.
As our patient, you'll have access to a wide range of clinical trials from both BMC researchers and researchers at other institutions. While we enroll any and all eligible patients in clinical trials, BMC physicians are in particular leaders in the enrollment of under-represented minorities in clinical trials.
Latest from HealthCity
BMC Is Poised to Enter the CAR T-Cell Therapy Clinical Trials Ecosystem
Pharmaceutical manufacturers are working to expand access to CAR T clinical trials by partnering with hospitals that care for diverse patients.
BMC Aims to Offer Costly, One-Time Cancer Therapy To All
CAR T, a personalized cell therapy, has been a game-changer for certain blood cancers, but its high cost has been a huge barrier to equitable access.
Patient Navigators Key in Closing Equity Gaps in Cancer Treatment
Historically marginalized communities are subject to delays across the spectrum of cancer care.
Anti-Racism Committee Works to Improve Cancer Care and Research
Eliminating the race-based health equity gap starts from within the department, says Boston University Chobanian & Avedisian School of Medicine
New Online Tool Helps Women Assess Their Cervical Cancer Risk
Using their own screening history, women can access the same type of personalized risk information that their doctors see.
HPV-Linked Throat Cancer Is Preventable. This Clinic Offers the Vaccine and Awareness.
BMC’s innovative clinic provides same-day shots and a chance to research barriers to vaccination.
Housing Segregation Is Associated with Delayed Lung Cancer Diagnoses
New research shows the need for increased lung cancer screening in areas that are highly segregated by race to better diagnose Black patients early.
Inadequate Cervical Cancer Screening Puts Women 65+ at Risk
Guidelines recommend discontinuing cervical cancer screening at 65, but new research shows that the majority of women don't meet the criteria to stop.
Partnership Targets Better Diversity in Cancer Clinical Trials
A new collaboration among Boston cancer centers aims to increase minority populations’ access to the latest treatments for more equitable outcomes.
Breast Cancer Survival Should Not Be Black or White
Black women die from breast cancer in higher rates than any other group. Major medical systems are collaborating to eliminate the growing disparity.
4 Transformative Takeaways on Equitable Healthcare From TEDx
Healthcare experts share forward-thinking views on the medical community’s role in providing effective, authentic, and sustainable care.
Etoposide and Other Clinical Trials for COVID-19 Inflammation
At Boston Medical Center, experts from the Cancer Center are exploring how new and existing therapies could fight the COVID infection.